{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:25:38Z","timestamp":1790663138458,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cld.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T07:18:17Z","timestamp":1493191097000},"page":"475-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Metabolic Manifestations of Hepatitis C Virus"],"prefix":"10.1016","volume":"21","author":[{"given":"Lawrence","family":"Serfaty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2017.03.004_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/00365521.2016.1228119","article-title":"Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden","volume":"52","author":"B\u00fcsch","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2017.03.004_bib2","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2017.03.004_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1478-3231.2008.01952.x","article-title":"Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data","volume":"29","author":"Serfaty","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2017.03.004_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2893.2005.00669.x","article-title":"Hepatitis C and steatosis: a reappraisal","volume":"13","author":"Lonardo","year":"2006","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2017.03.004_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0168-8278(00)00036-2","article-title":"Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C","volume":"34","author":"Serfaty","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2017.03.004_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.21711","article-title":"Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study","volume":"46","author":"Bedossa","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gut.2004.050302","article-title":"Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C","volume":"54","author":"Fartoux","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cld.2017.03.004_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/jhep.2003.50267","article-title":"Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C","volume":"38","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2010.12.020","article-title":"Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis","volume":"55","author":"Cai","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2017.03.004_bib10","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s10620-012-2171-y","article-title":"The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection","volume":"57","author":"Clark","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2017.03.004_bib11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1056\/NEJMc1307641","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection (Letter)","volume":"369","author":"Hsu","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2017.03.004_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb1631","article-title":"The lipid droplet is an important organelle for hepatitis C virus production","volume":"9","author":"Miyanari","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.cld.2017.03.004_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4161\/rna.8.2.15011","article-title":"Hepatitis C virus and host cell lipids: an intimate connection","volume":"8","author":"Alvisi","year":"2011","journal-title":"RNA Biol"},{"key":"10.1016\/j.cld.2017.03.004_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","article-title":"Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis","volume":"16","author":"Perlemuter","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.cld.2017.03.004_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/j.gastro.2004.11.016","article-title":"Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection","volume":"128","author":"Dharancy","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2017.03.004_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbrc.2007.02.044","article-title":"HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma","volume":"355","author":"Kim","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cld.2017.03.004_bib17","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/hep.25990","article-title":"Elevated lipogenesis and diminished cholesterol synthesis in patients with hepatitis C viral infection compared to healthy humans","volume":"57","author":"Lambert","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib18","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1128\/JVI.01653-14","article-title":"Hepatitis C virus attenuates mitochondrial lipid \u03b2-oxidation by downregulating mitochondrial trifunctional-protein expression","volume":"89","author":"Amako","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cld.2017.03.004_bib19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2004.12.034","article-title":"An in\u00a0vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation","volume":"42","author":"Abid","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2017.03.004_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jhep.2006.10.019","article-title":"Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core","volume":"46","author":"Jackel-Cram","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2017.03.004_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.2006.02729.x","article-title":"Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection","volume":"23","author":"de Gottardi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2017.03.004_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.25631","article-title":"Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner","volume":"56","author":"Clark","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib23","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2006.02.035","article-title":"Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis","volume":"130","author":"Mirandola","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2017.03.004_bib24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2337\/diacare.24.2.362","article-title":"Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes","volume":"24","author":"Katsuki","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cld.2017.03.004_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.cld.2017.03.004_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2337\/diabetes.54.2.333","article-title":"Identification of individuals with insulin resistance using routine clinical measurements","volume":"54","author":"Stern","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.cld.2017.03.004_bib27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0168-8278(05)80631-2","article-title":"Evidence for a link between hepatitis C\u00a0virus infection and diabetes mellitus in a cirrhotic population","volume":"21","author":"Allison","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2017.03.004_bib29","first-page":"544","article-title":"High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case\u2013control study","volume":"20","author":"Grimbert","year":"1996","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cld.2017.03.004_bib30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/hep.510300416","article-title":"Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection","volume":"30","author":"Caronia","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s005350300063","article-title":"Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus","volume":"38","author":"Arao","year":"2003","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cld.2017.03.004_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1478-3231.2007.01630.x","article-title":"Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients","volume":"28","author":"Imazeki","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2017.03.004_bib33","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.3748\/wjg.v16.i27.3427","article-title":"Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection","volume":"16","author":"Rouabhia","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2017.03.004_bib34","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2017.03.004_bib35","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3748\/wjg.v18.i14.1642","article-title":"Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis","volume":"18","author":"Naing","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2017.03.004_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2017.03.004_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000282103","article-title":"Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes","volume":"28","author":"Mihm","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.cld.2017.03.004_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1478-3231.2007.01626.x","article-title":"High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C","volume":"28","author":"Hsu","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2017.03.004_bib39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2893.2006.00836.x","article-title":"Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients","volume":"14","author":"Yoneda","year":"2007","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2017.03.004_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1742-1241.2002.tb11227.x","article-title":"Increased frequency of HCV but not HBV infection in type 2 diabetic patients in Turkey","volume":"56","author":"Okan","year":"2002","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.cld.2017.03.004_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0168-8227(99)00135-7","article-title":"Increased frequency of HCV and HBV infection in type 2 diabetic patients","volume":"48","author":"Sangiorgio","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.cld.2017.03.004_bib42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/diacare.19.9.998","article-title":"High prevalence of hepatitis C virus infection in diabetic patients","volume":"19","author":"Simo","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cld.2017.03.004_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes","volume":"38","author":"Mehta","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib44","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwm061","article-title":"Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study","volume":"166","author":"Wang","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cld.2017.03.004_bib45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/lt.21267","article-title":"Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance","volume":"14","author":"Delgado-Borrego","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2017.03.004_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1872-034X.2007.00280.x","article-title":"Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C.","volume":"38","author":"Mitsuyoshi","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2017.03.004_bib47","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2012.04.036","article-title":"Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C","volume":"57","author":"St\u00e4ttermayer","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2017.03.004_bib48","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/jvh.12408","article-title":"Association between IL28B polymorphism, TNF\u03b1 and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance","volume":"22","author":"Lemoine","year":"2015","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2017.03.004_bib49","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1572-0241.2006.01038.x","article-title":"Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2","volume":"102","author":"Kawaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2017.03.004_bib50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2006.05.016","article-title":"Peginterferon-alfa2a plus ribavirin for 48 versus 72\u00a0weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment","volume":"131","author":"Sanchez-Tapias","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2017.03.004_bib51","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.22703","article-title":"Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C","volume":"49","author":"Arase","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib52","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2017.03.004_bib53","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ajg.2013.90","article-title":"Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy","volume":"108","author":"Montenegro","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2017.03.004_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2893.2011.01554.x","article-title":"Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity","volume":"19","author":"Stepanova","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2017.03.004_bib55","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/apt.12234","article-title":"Associations of chronic hepatitis C with metabolic and cardiac outcomes","volume":"37","author":"Younossi","year":"2013","journal-title":"Ali Ment Pharmacol Ther"},{"key":"10.1016\/j.cld.2017.03.004_bib56","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.27047","article-title":"Relationship of hepatitis C virus infection with diabetes in the U.S. population","volume":"60","author":"Ruhl","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib57","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/jvh.12520","article-title":"Matched population-based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C virus infection","volume":"23","author":"Schnier","year":"2016","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2017.03.004_bib58","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1053\/jhep.2003.09012","article-title":"Impaired IRS-1\/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes","volume":"38","author":"Aytug","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib59","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2017.03.004_bib60","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)63408-6","article-title":"Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3","volume":"165","author":"Kawaguchi","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cld.2017.03.004_bib61","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.21634","article-title":"The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms","volume":"45","author":"Pazienza","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib62","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/JVI.01683-06","article-title":"Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein","volume":"81","author":"Miyamoto","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cld.2017.03.004_bib63","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1099\/vir.0.020644-0","article-title":"Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells","volume":"91","author":"Pazienza","year":"2010","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.cld.2017.03.004_bib64","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.21611","article-title":"Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A","volume":"46","author":"Christen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib65","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2337\/dc05-2509","article-title":"Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study","volume":"29","author":"Lecube","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cld.2017.03.004_bib66","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/j.1572-0241.2003.08728.x","article-title":"Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association","volume":"98","author":"Knobler","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2017.03.004_bib67","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1365-2036.2006.03114.x","article-title":"Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin\/tumour necrosis factor-alpha in chronic hepatitis C patients","volume":"24","author":"Durante-Mangoni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2017.03.004_bib68","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gut.46.2.260","article-title":"Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection","volume":"46","author":"McGuinness","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cld.2017.03.004_bib69","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/hep.23031","article-title":"Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C","volume":"50","author":"Vanni","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.03.004_bib70","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/j.gastro.2009.11.050","article-title":"Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance","volume":"138","author":"Milner","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2017.03.004_bib71","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI117495","article-title":"Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha","volume":"94","author":"Hotamisligil","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2017.03.004_bib72","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/gast.2002.30983","article-title":"Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein","volume":"122","author":"Okuda","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2017.03.004_bib73","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/gast.2002.31001","article-title":"Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus","volume":"122","author":"Lerat","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2017.03.004_bib74","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1440-1746.2007.05183.x","article-title":"Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance","volume":"23","author":"Itou","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2017.03.004_bib75","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2337\/diacare.28.4.940","article-title":"Hepatitis C virus infection and human pancreatic beta-cell dysfunction","volume":"28","author":"Masini","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cld.2017.03.004_bib76","doi-asserted-by":"crossref","first-page":"e38522","DOI":"10.1371\/journal.pone.0038522","article-title":"Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326117300211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326117300211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T08:35:05Z","timestamp":1692779705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326117300211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1089326117300211"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2017.03.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Manifestations of Hepatitis C Virus","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}